DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ufer M.
Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development.
Thromb Haemost 2010;
103 (3) 572-585
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.